4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-105576
Chief Technical Officer sold 9,748 shares at $115.24 ($1,123,398)
- Chief Technical Officer acquired 9,748 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-10-30 | Option exercise 10b5-1 | +9,748 | $30.66 | $298,874 | 18,257 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-30 | Sale 10b5-1 | −9,748 | $115.24 | $1,123,398 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-10-30 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −9,748 | 0 | D | ||
| Open-market sales · 9,748 sh · avg $115.24 · $1,123,398 | |||||||
Loading xslF345X05/tm2530076-1_4seq1.xml…